Mammography CAD developer Scanis is gearing up its global efforts in preparation for the launch of its Mammex TR system. The Foster City, CA-based firm has established a European marketing office in Eindhoven, the Netherlands. The office will be led by
Mammography CAD developer Scanis is gearing up its global efforts in preparation for the launch of its Mammex TR system. The Foster City, CA-based firm has established a European marketing office in Eindhoven, the Netherlands. The office will be led by Theo Spangenberg, who has been named European marketing director.
Scanis expects Mammex TR will be available in Europe in the first quarter. The unit has completed preclinical evaluation at the Norris Comprehensive Cancer Center at the University of Southern California (SCAN Special Report, January 2000), and was also recently installed at the Klinik Hirslanden in Zurich, Switzerland, where it will undergo further evaluation. Mammex TR was developed jointly with the TRW Center for Medical Image Analysis (SCAN 10/15/97).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.